Publication:
Should we cross off the crossover? [editorial]

Simple item page
dc.contributor.authorP. Armitageen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-10T08:35:00Z
dc.date.available2018-08-10T08:35:00Z
dc.date.issued1991-01-01en_US
dc.identifier.citationBritish Journal of Clinical Pharmacology. Vol.32, No.1 (1991), 1-2en_US
dc.identifier.doi10.1111/j.1365-2125.1991.tb05604.xen_US
dc.identifier.issn13652125en_US
dc.identifier.issn03065251en_US
dc.identifier.other2-s2.0-84982393046en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/22187
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84982393046&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleShould we cross off the crossover? [editorial]en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84982393046&origin=inwarden_US

Files

Collections

Scopus 1991-2000